Axol Bioscience acquires Phenocell to advance human disease models

Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today announced it has fully acquired Phenocell SAS, a pioneer in iPSC-based products and bioassays for skin and retinal disorders.

New review highlights top strategies for smoking cessation

A major new scientific review of evidence published in the journal Addiction has identified three top strategies for quitting smoking.

September 5, 2024

$550,000 grant supports VT researchers to study the effects of changing food spending patterns

After a long day, there’s the age-old question of do we eat out or stay in? Over the last decade, that answer has increasingly shifted

January 2, 2024

New England Journal of Medicine reckons with its racist past and complicity in slavery

The New England Journal of Medicine, the world’s oldest continually published medical journal, publicly reckoned with its history and complicity surrounding slavery and racism Wednesday,

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.